Nexo Therapeutics, Inc. — Form D/A

Nexo Therapeutics, Inc. of LITTLETON, CO, a company, filed a Form D amendment with the SEC on 2026-03-27. The offering totals $60.0M, of which $60.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-03-27
• Form: D/A
• Accession: 0001955319-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $60.0M
• Amount sold: $60.0M
• Investors: 7
• Date of first sale: 2022-11-15
• Security types: equity, debt
• Revenue range: Decline to Disclose
• SEC file number: 021-465438

Issuer

• Name: Nexo Therapeutics, Inc.
• CIK: 0001955319
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2022
• Address: 11757 W. KEN CARYL AVENUE, LITTLETON, CO, 80127-3719
• Phone: 303-868-6790

Officers, directors & promoters (8)

Other filings by this issuer (3)

More

• CIK 1955319 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search